<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Investig Clin Urol</journal-id><journal-id journal-id-type="iso-abbrev">Investig Clin Urol</journal-id><journal-id journal-id-type="publisher-id">ICU</journal-id><journal-title-group><journal-title>Investigative and Clinical Urology</journal-title></journal-title-group><issn pub-type="ppub">2466-0493</issn><issn pub-type="epub">2466-054X</issn><publisher><publisher-name>The Korean Urological Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28097266</article-id><article-id pub-id-type="pmc">5240290</article-id><article-id pub-id-type="doi">10.4111/icu.2017.58.1.34</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject><subj-group subj-group-type="subheading"><subject>Lower Urinary Tract Dysfunction</subject></subj-group></subj-group></article-categories><title-group><article-title>The effect of posture and repetition on urodynamic parameters: A prospective randomized study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jeon</surname><given-names>Ho Joon</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Choo</surname><given-names>Min Soo</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Oh</surname><given-names>Seung-June</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Urology, Seoul National University Hospital, Seoul, Korea.</aff><aff id="A2"><label>2</label>Department of Urology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.</aff><author-notes><corresp>
Corresponding Author: Seung-June Oh. Department of Urology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea. TEL: +82-2-2072-2406, FAX: +82-2-742-4665, <email>sjo@snu.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>09</day><month>1</month><year>2017</year></pub-date><volume>58</volume><issue>1</issue><fpage>34</fpage><lpage>41</lpage><history><date date-type="received"><day>10</day><month>10</month><year>2016</year></date><date date-type="accepted"><day>23</day><month>10</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Korean Urological Association, 2017</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>To evaluate the effect of posture and repetition of filling cystometry on urodynamic parameters.</p></sec><sec><title>Materials and Methods</title><p>Seventy-one men with benign prostatic hyperplasia participated in a urodynamic study between September 2015 and August 2016 and were randomly assigned to a supine to supine (group SS, n=16), erect to erect (group EE, n=16), supine to erect (group SE, n=19) or erect to supine (group ES, n=20) group. The patients underwent filling cystometry twice. We evaluated the effect of posture and the effect of repetition on filling cystometric parameters. We also evaluated the correlation between overactive bladder (OAB) and detrusor overactivity (DO) and between maximum voided volume (MVV) and maximum cystometric capacity (MCC) for each posture and filling cystometry time.</p></sec><sec><title>Results</title><p>There was a decrease in bladder sensation and occurrence of DO, and an increase in bladder compliance and MCC in the supine posture group compared to that in the erect posture group. A more significant decrease in bladder sensation and occurrence of DO as well as an increase in MCC was seen during the second filling cystometry than the first one. The supine posture during first filling cystometry showed a better correlation between OAB and DO and between MVV and MCC than erect posture.</p></sec><sec><title>Conclusions</title><p>There were clear effects of posture and filling cystometry repetition on urodynamic parameters. The supine posture and repeated filling cystometry caused the bladder to be less sensitive and less overactive. The supine posture showed a better correlation to OAB symptoms than erect posture during first filling cystometry.</p></sec></abstract><kwd-group><kwd>Lower urinary tract symptoms</kwd><kwd>Posture</kwd><kwd>Urodynamics</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Urodynamic study (UDS) is considered the gold standard for investigating the cause of lower urinary tract symptoms (LUTS) [<xref rid="B1" ref-type="bibr">1</xref>]. Involuntary detrusor contraction during filling cystometry is called urodynamic detrusor overactivity (DO) and may help to predict the outcome of transurethral prostatic surgery and influence treatment options [<xref rid="B2" ref-type="bibr">2</xref>]. Strict indication, quality control, and accurate analysis are needed as UDS is invasive, expensive, and can cause discomfort and complications [<xref rid="B3" ref-type="bibr">3</xref>]. Although filling cystometry as part of UDS can be measured in the supine, erect, or even sitting posture, there is no clear consensus about the optimal posture during filling cystometry in the international guidelines of UDS [<xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">4</xref>]. However, it is recommended that repeating filling cystometry in a different posture can be helpful when it is deemed clinically necessary [<xref rid="B5" ref-type="bibr">5</xref>].</p><p>It has been reported that posture and repetition of filling cystometry can influence urodynamic parameters. Awad and McGinnis [<xref rid="B6" ref-type="bibr">6</xref>] measured DO in 30% of women with urinary incontinence in supine posture versus 61% in the erect posture. Al-Hayek et al. [<xref rid="B7" ref-type="bibr">7</xref>] performed a systematic review and concluded that supine posture during filling cystometry would fail to detect a significant percentage of patients with DO. Ockrim et al. [<xref rid="B8" ref-type="bibr">8</xref>] observed a DO of 72%, 63%, and 48%, in the 3 sequential UDS, respectively.</p><p>To our knowledge, there has been no prospective randomized study on the combination of posture and repetition of filling cystometry. The aims of this study were to investigate the effect of posture and repetition of filling cystometry on urodynamic parameters and elucidate which posture might better correlate to patient symptoms.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>1. Patients and study design</title><p>A prospective randomized study was performed enrolling patients with benign prostatic hyperplasia (BPH) presenting to the urology department of Seoul National University Hospital (SNUH). The patients were recruited between September 2015 and August 2016. Inclusion criteria of this study included patients with LUTS/BPH aged over 45 scheduled for UDS in our urology outpatient clinic. Exclusion criteria included neurogenic bladder, bladder stone, acute urinary tract infection within one month, previous administration of anticholinergics within one month, history of prostate or bladder surgery, genitourinary cancer, urethral stricture, renal or hepatic insufficiency, serum prostate-specific antigen (PSA) higher than 10 ng/dL or patients who could not undergo UDS in a supine or erect posture. The following examinations were carried out for assessment: patient history, digital rectal examination, International Prostate Symptom Score (IPSS), overactive bladder symptom score (OABSS), frequency volume chart (FVC), serum PSA, and transrectal ultrasonography of the prostate. After informed consent was obtained, the patients were randomly assigned to one of 4 groups (SS [supine to supine], EE [erect to erect], ES [erect to supine], and SE [supine to erect]) (1:1:1:1) using an online randomization system at our hospital [<xref rid="B9" ref-type="bibr">9</xref>]. The patients then underwent UDS with 2-time filling cystometry in the assigned postures as described above. The Institutional Review Board of SNUH approved the study design (approval number: H-1507-128-689). Written informed consent was obtained from each participant. This study was performed according to the Helsinki Declaration.</p></sec><sec><title>2. Sample size</title><p>The sample size was calculated based on the data from review article of Al-Hayek et al. [<xref rid="B7" ref-type="bibr">7</xref>]. The incidence of DO in the supine posture was 11% and that in the erect posture was 48% in the article. The sample size calculation showed that 48 patients are required to have 80% power for detecting a significant difference of DO between the supine and erect postures. The aims of our study were not only to investigate the effect of posture but also to investigate the effect of repetition. Therefore, we decided to recruit double the number indicated in the calculated sample size. Finally, we planned 1-year recruitment of participants; the number of participants needed at least 48 and at most 96. We conducted mid-term analysis when the number of participants was 42. A significant difference in the occurrence of DO was seen between the supine and erect postures. However, other filling cystometric parameters showed no significant differences and the effect of repetition was not clear. Therefore, we decided to recruit more participants; the final number of participants was seventy one after 1-year recruitment.</p></sec><sec><title>3. Urodynamic procedures</title><p>The urodynamic procedures were carried out according to the guidelines of the International Continence Society [<xref rid="B1" ref-type="bibr">1</xref>]. The procedure and potential complications of UDS were explained to each patient a few days before the procedure. Immediately before the UDS was performed, medical history and laboratory data for each patient were collected for selecting candidates. Then the study design was explained to candidates and written informed consent was obtained from each participant. Participants were then registered on the online randomization system of our hospital [<xref rid="B9" ref-type="bibr">9</xref>] and randomly assigned to each previously mentioned group. Conventional UDS was carried out by the same nurse practitioners using the same protocol (UD-2000, Medical Measurement System, Enschede, The Netherlands) but filling cystometry was performed twice in the previously assigned postures.</p><p>The UDS procedure was as follows. First, free uroflowmetry was performed. Filling cystometry was then performed in the first assigned posture with normal saline mixed with contrast dyes at a filling rate of 50 mL/min at room temperature. An aseptic dual-lumen 6-French catheter (Medtronic Inc., Skovlunde, Denmark) was inserted to measure vesical pressure and infuse fluids. A rectal balloon catheter (Medical Measurement System) was inserted into the rectum to measure abdominal pressure. Then, a pressure flow study was performed and the second filling cystometry performed in the second assigned posture. Subsequently, a pressure flow study was performed, but only once or not at all in case of urinary incontinence or voiding failure. Finally, urethral pressure measurement was performed.</p></sec><sec><title>4. Clinical and urodynamic parameters</title><p>All patients underwent a baseline evaluation including the following: age, body mass index, IPSS, OABSS, prostate volume of transrectal ultrasonography of the prostate, and FVC. We examined total IPSS score, IPSS voiding subscore, and IPSS storage subscore. Overactive bladder (OAB) was diagnosed as an urgency score of OABSS &#x02265;2 and a total score of at least 3 [<xref rid="B10" ref-type="bibr">10</xref>]. Maximum voided volume (MVV), 24-hour frequency, nocturia, and 24-hour production were examined in FVC.</p><p>Urodynamic parameters were also investigated. Maximal flow rate (Qmax) and postvoid residual urine volume were measured during uroflowmetry. First sensation of filling (FSF), first desire to void (FDV), strong desire to void (SDV), maximum cystometric capacity (MCC), bladder compliance, and DO were measured during filling cystometry. Bladder outlet obstruction index was measured during the pressure flow study using the following formula: detrusor pressure at maximum flow rate &#x02013; 2 Qmax [<xref rid="B11" ref-type="bibr">11</xref>]. Maximum urethral closure pressure (MUCP) was measured during urethral pressure measurement. MCC was defined as the bladder volume at which the patient complained that they could not suppress urination, or at which time the filled volume reached 550 mL or 600 mL (in cases where MVV was over 550 mL). DO was defined as involuntary detrusor contraction over 5 cmH<sub>2</sub>O; volume and pressure of DO were also documented. If involuntary detrusor contraction occurred multiple times, the minimum volume and maximum pressure of DO were documented.</p></sec><sec><title>5. Effect of repetition and posture of filling cystometry on UDS parameters</title><p>Groups SS and EE underwent filling cystometry twice without a postural change; groups SE and ES underwent filling cystometry twice with a postural change. Thus, there was only an effect of repetition in groups SS and EE, while there was combined effect of repetition and postural change in groups SE and ES. The effect of repetition was evaluated by comparing the first filling cystometry with the second filling cystometry in the same posture groups. The effect of posture was evaluated by comparing supine posture with erect posture during the first filling cystometry.</p></sec><sec><title>6. Correlation between symptom and UDS parameters</title><p>The patients were also divided in 2 by 2 groups for each posture and filling cystometry time. For example, the patients of groups SS and SE underwent the first filling cystometry in the supine posture and the patients of groups SE and EE underwent the second filling cystometry in the erect posture. We also evaluated the correlation between DO and OAB and between MVV and MCC in each posture and filling cystometry time.</p></sec><sec><title>7. Statistical analysis</title><p>All parameters are represented by mean&#x000b1;standard deviation or number (percentage). One way analysis of variance was used to evaluate the difference between 4 groups. Paired samples t-test and McNemar test were used to evaluate the difference in filling cystometric parameters by repetition of filling cystometry in the same group. Two sample t-test and chi-square test were used to compare supine posture with erect posture during the first filling cystometry. Cohen Kappa was used to compare OAB with DO. Intraclass correlation coefficient (ICC) was used to compare MVV with MCC. Statistical significance was set at a p-value of less than 0.05. A Cohen Kappa of 0 to 0.20 was considered to be in slight agreement, 0.21 to 0.40 was considered fair agreement, and 0.41to 0.60 was considered moderate agreement [<xref rid="B12" ref-type="bibr">12</xref>]. An ICC value less than 0.40 was considered poor agreement, 0.40 to 0.59 was considered fair agreement, and 0.60 to 0.74 was considered good agreement, and 0.75 to 1.00 was considered excellent agreement [<xref rid="B13" ref-type="bibr">13</xref>].</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>1. Patient demographics</title><p>Patient demographics were shown in <xref ref-type="table" rid="T1">Table 1</xref>. There was no significant difference in clinical parameters between the 4 groups (p&#x0003e;0.05).</p></sec><sec><title>2. Effect of repetition of filling cystometry on UDS parameters</title><p>The changes of filling cystometric parameters in each group by repetition of filling cystometry were shown in <xref ref-type="table" rid="T2">Table 2</xref>. There were several significant differences by repetition of filling cystometry. FSF (p=0.017) and FDV (p=0.017) were significantly different in group SS; minimum volume of DO was significantly different in group EE (p=0.007).</p></sec><sec><title>3. Effect of posture of filling cystometry on UDS parameters</title><p>The comparison of clinical and urodynamic parameters between supine and erect posture during the first filling cystometry was shown in <xref ref-type="table" rid="T3">Table 3</xref>. All filling cystometric parameters showed significant differences between supine group and erect group for the first filling cystometry (p&#x0003c;0.05). OAB diagnosis and all of urodynamic parameters except filling cystometric parameters showed no significant difference, but MUCP showed a significant difference during the first filling cystometry (p=0.038).</p></sec><sec><title>4. Combined effect of posture and repetition of filling cystometry on UDS parameters</title><p>SDV (p=0.018), MCC (p=0.009), occurrence of DO (p=0.031), minimum volume of DO (p=0.008) and maximum pressure of DO (p=0.003) showed significant differences in group SE; all filling cystometric parameters showed significant differences in group ES (p&#x0003c;0.01) (<xref ref-type="table" rid="T2">Table 2</xref>).</p></sec><sec><title>5. Correlation between symptom and UDS parameters</title><p>Supine posture during the first filling cystometry (&#x003ba;=0.329; 95% confidence internal [CI], 0.037&#x02013;0.621) and erect posture during the second filling cystometry (0.375; 95% CI, 0.152&#x02013;0.598) showed a better correlation to OAB symptoms compared to that in the other groups. In predicting OAB using DO during filling cystometry, supine posture during the first filling cystometry showed the highest specificity (81.3%) and erect posture during the second f illing cystometry showed the highest sensitivity (100%).</p><p>The correlation between MVV of FVC and MCC during filling cystometry is shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>. Supine posture during the first filling cystometry showed the best correlation between MVV and MCC (ICC=0.669; 95% CI, 0.431&#x02013;0.819).</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The primary aim of UDS is to reproduce the patient's symptoms [<xref rid="B7" ref-type="bibr">7</xref><xref rid="B14" ref-type="bibr">14</xref>]. Especially, filling cystometry is used to reproduce the storage phase of the bladder so that bladder sensation, bladder capacity, bladder compliance, and detrusor function can be evaluated through filling cystometry [<xref rid="B1" ref-type="bibr">1</xref>]. The UDS is the key to exploring the correlation between DO and OAB symptoms [<xref rid="B7" ref-type="bibr">7</xref>], but many factors can affect the occurrence of DO, including the temperature of the fluid, rate of filling, posture, repetition, and irritation by the catheter [<xref rid="B7" ref-type="bibr">7</xref><xref rid="B8" ref-type="bibr">8</xref>]. Due to these factors, the standard UDS has limitations in reproducing the physiological condition of the bladder; even in ambulatory UDS it is difficult to avoid catheter irritation completely [<xref rid="B14" ref-type="bibr">14</xref>]. Consequently, in our opinion, standard UDS is a more irritating condition compared to the natural physiological condition of the bladder.</p><p>The erect posture could trigger DO. Geirsson and Fall [<xref rid="B15" ref-type="bibr">15</xref>] reported that cold stimulation of the urethra caused a reflexive bladder contraction. During sitting or erect posture, some urine might enter the proximal urethra, which can stimulate DO [<xref rid="B7" ref-type="bibr">7</xref>]. The repetition of filling cystometry could have a suppressive effect on DO. Ockrim et al. [<xref rid="B8" ref-type="bibr">8</xref>] and Y&#x00131;ld&#x00131;z et al. [<xref rid="B16" ref-type="bibr">16</xref>] reported that repeated filling cystometry resulted in a reduced occurrence of DO.</p><p>In our study, the filling rate was 50 mL per minute and temperature of the fluid was room temperature. These factors might influence the occurrence of DO; therefore, we believed that supine posture during the first filling cystometry would offset irritating conditions. During the second filling cystometry, erect posture was shown a better correlation to OAB symptom than supine posture due to the effect of repetition.</p><p>Many studies have shown the correlation between posture and DO. Al-Hayek et al. [<xref rid="B7" ref-type="bibr">7</xref>] reported a review article on the effect of posture on the occurrence of DO. Sixteen articles were analyzed and there was a clear trend of reduced occurrence of DO in supine posture. However, some of these articles did not match DO and clinical parameters, and ignored the effect of repetition. In our study, patients were randomly assigned to the supine or erect posture, and the effect of posture was clearly shown. Supine posture caused the bladder to be less sensitive and less overactive. Ockrim et al. [<xref rid="B8" ref-type="bibr">8</xref>] and Y&#x00131;ld&#x00131;z et al. [<xref rid="B16" ref-type="bibr">16</xref>] reported the effect of repeated filling cystometry. They showed a trend of reduced bladder sensation and reduced occurrence of DO when filling cystometry was repeated. This trend was also seen in our study.</p><p>We evaluated the correlation between OAB and DO and between MVV and MCC. OAB and DO are different conditions, even though the overlap between them is substantial. OAB is a symptom-based diagnosis characterized by urinary urgency, while DO is a urodynamic observation characterized by involuntary detrusor contractions during filling cystometry [<xref rid="B1" ref-type="bibr">1</xref>]. Many of those with OAB do not have DO and those with DO do not always have urgency issues [<xref rid="B17" ref-type="bibr">17</xref>]. MVV and MCC are also different measurements even though they are very similar concepts. Although urodynamic parameters cannot perfectly correspond to symptoms, one principle is clear: the posture which shows the best correlation between urodynamic parameters and symptoms would be the most desirable posture. In our study, the supine posture during the first filling cystometry showed a better correlation between OAB and DO and between MVV and MCC compared to the others. Thus, we suggest that the supine posture is the ideal proper posture for the first filling cystometry.</p><p>There were several limitations in this study. First, we recruited only patients with BPH; other diseases, including neurogenic bladder, were excluded. This selection made participants homogeneous, and our results cannot represent other urologic conditions such as urinary incontinence and neurogenic bladder. Moreover, patient symptoms might be more severe compared to that in typical patients with BPH. Generally, we performed UDS in those who might undergo BPH surgery or who complained of severe symptoms. Second, we did not perform filling cystometry in the sitting posture. Adding sitting posture would be better choice to have a more complete evaluation of the effect of posture, but it would take larger group and more time. We decided to perform our study with the supine or erect postures because Al-Hayek et al. [<xref rid="B7" ref-type="bibr">7</xref>] reported that the most change occurred between the supine and erect posture.</p></sec><sec sec-type="conclusions"><title>CONCLUSIONS</title><p>There were significant differences in urodynamic parameters between the supine posture and erect posture and between the first filling cystometry and the second filling cystometry. Supine posture and repetition of filling cystometry caused the bladder to be less sensitive and less overactive. Supine posture showed a better correlation to patient's symptoms compared to that in the erect posture during the first filling cystometry.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>Kwi-Shik Kim and So Hee Shin provided technical support. Yu-Kyung Lee assisted with the database management.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>CONFLICTS OF INTEREST:</bold> The authors have nothing to disclose.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname><given-names>P</given-names></name><name><surname>Cardozo</surname><given-names>L</given-names></name><name><surname>Fall</surname><given-names>M</given-names></name><name><surname>Griffiths</surname><given-names>D</given-names></name><name><surname>Rosier</surname><given-names>P</given-names></name><name><surname>Ulmsten</surname><given-names>U</given-names></name><etal/></person-group><article-title>The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society</article-title><source>Neurourol Urodyn</source><year>2002</year><volume>21</volume><fpage>167</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">11857671</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitti</surname><given-names>VW</given-names></name></person-group><article-title>Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction</article-title><source>Rev Urol</source><year>2005</year><volume>7</volume><issue>Suppl 6</issue><fpage>S14</fpage><lpage>S21</lpage><pub-id pub-id-type="pmid">16986024</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000e4;fer</surname><given-names>W</given-names></name><name><surname>Abrams</surname><given-names>P</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name><name><surname>Mattiasson</surname><given-names>A</given-names></name><name><surname>Pesce</surname><given-names>F</given-names></name><name><surname>Spangberg</surname><given-names>A</given-names></name><etal/></person-group><article-title>Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies</article-title><source>Neurourol Urodyn</source><year>2002</year><volume>21</volume><fpage>261</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">11948720</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winters</surname><given-names>JC</given-names></name><name><surname>Dmochowski</surname><given-names>RR</given-names></name><name><surname>Goldman</surname><given-names>HB</given-names></name><name><surname>Herndon</surname><given-names>CD</given-names></name><name><surname>Kobashi</surname><given-names>KC</given-names></name><name><surname>Kraus</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Urodynamic studies in adults: AUA/SUFU guideline</article-title><source>J Urol</source><year>2012</year><volume>188</volume><issue>6 Suppl</issue><fpage>2464</fpage><lpage>2472</lpage><pub-id pub-id-type="pmid">23098783</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hosker</surname><given-names>G</given-names></name><name><surname>Rosier</surname><given-names>P</given-names></name><name><surname>Gajewski</surname><given-names>J</given-names></name><name><surname>Sand</surname><given-names>P</given-names></name><name><surname>Szabo</surname><given-names>L</given-names></name><name><surname>Capewell</surname><given-names>A</given-names></name></person-group><chapter-title>Dynamic testing</chapter-title><person-group person-group-type="editor"><name><surname>Abrams</surname><given-names>P</given-names></name><name><surname>Cardozo</surname><given-names>L</given-names></name><name><surname>Khury</surname><given-names>S</given-names></name><name><surname>Wein</surname><given-names>A</given-names></name></person-group><source>Incontinence: 4th International Consultation on Incontinence</source><publisher-loc>Plymouth</publisher-loc><publisher-name>Health Publications Ltd.</publisher-name><year>2009</year><fpage>413</fpage><lpage>522</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awad</surname><given-names>SA</given-names></name><name><surname>McGinnis</surname><given-names>RH</given-names></name></person-group><article-title>Factors that influence the incidence of detrusor instability in women</article-title><source>J Urol</source><year>1983</year><volume>130</volume><fpage>114</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">6683325</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Hayek</surname><given-names>S</given-names></name><name><surname>Belal</surname><given-names>M</given-names></name><name><surname>Abrams</surname><given-names>P</given-names></name></person-group><article-title>Does the patient's position influence the detection of detrusor overactivity?</article-title><source>Neurourol Urodyn</source><year>2008</year><volume>27</volume><fpage>279</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">17724734</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ockrim</surname><given-names>J</given-names></name><name><surname>Laniado</surname><given-names>ME</given-names></name><name><surname>Khoubehi</surname><given-names>B</given-names></name><name><surname>Renzetti</surname><given-names>R</given-names></name><name><surname>Finazzi Agr&#x000f2;</surname><given-names>E</given-names></name><name><surname>Carter</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Variability of detrusor overactivity on repeated filling cystometry in men with urge symptoms: comparison with spinal cord injury patients</article-title><source>BJU Int</source><year>2005</year><volume>95</volume><fpage>587</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">15705085</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="book"><source>Seoul National University Hospital Biomedical Research Institute [Internet]</source><publisher-loc>Seoul</publisher-loc><publisher-name>Medical Research Collaborating Center Seoul National University Hospital</publisher-name><year>c2004</year><date-in-citation content-type="access-date">cited 2004 Aug 1</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://mrcc.snuh.org/">http://mrcc.snuh.org/</ext-link></comment></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>O</given-names></name><name><surname>Nishizawa</surname><given-names>O</given-names></name><name><surname>Takeda</surname><given-names>M</given-names></name><name><surname>Yokoyama</surname><given-names>O</given-names></name><name><surname>Homma</surname><given-names>Y</given-names></name><name><surname>Kakizaki</surname><given-names>H</given-names></name><etal/></person-group><article-title>Clinical guidelines for overactive bladder</article-title><source>Int J Urol</source><year>2009</year><volume>16</volume><fpage>126</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">19228224</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>CS</given-names></name><name><surname>Abrams</surname><given-names>P</given-names></name></person-group><article-title>The Abrams-Griffiths nomogram</article-title><source>World J Urol</source><year>1995</year><volume>13</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">7539679</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landis</surname><given-names>JR</given-names></name><name><surname>Koch</surname><given-names>GG</given-names></name></person-group><article-title>The measurement of observer agreement for categorical data</article-title><source>Biometrics</source><year>1977</year><volume>33</volume><fpage>159</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">843571</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicchetti</surname><given-names>DV</given-names></name></person-group><article-title>Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology</article-title><source>Psychol Assess</source><year>1994</year><volume>6</volume><fpage>284</fpage><lpage>290</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname><given-names>P</given-names></name></person-group><article-title>Describing bladder storage function: overactive bladder syndrome and detrusor overactivity</article-title><source>Urology</source><year>2003</year><volume>62</volume><issue>5 Suppl 2</issue><fpage>28</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">14662404</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geirsson</surname><given-names>G</given-names></name><name><surname>Fall</surname><given-names>M</given-names></name></person-group><article-title>Reflex interaction between the proximal urethra and the bladder. A clinical experimental study</article-title><source>Scand J Urol Nephrol</source><year>1999</year><volume>33</volume><fpage>24</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">10100359</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Y&#x00131;ld&#x00131;z</surname><given-names>N</given-names></name><name><surname>Alkan</surname><given-names>H</given-names></name><name><surname>Sarsan</surname><given-names>A</given-names></name><name><surname>Alkan</surname><given-names>S</given-names></name></person-group><article-title>The effects of repeated filling cystometries on cystometric variables in spinal cord-injured patients with overactive detrusor, who utilize different type of urine drainage methods</article-title><source>Spinal Cord</source><year>2015</year><volume>53</volume><fpage>625</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">25708664</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>E</given-names></name><name><surname>Drake</surname><given-names>M</given-names></name></person-group><article-title>Overactive bladder</article-title><source>Maturitas</source><year>2010</year><volume>66</volume><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">20399043</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>Scatter plot and intraclass correlation coefficient (ICC) between maximum voided volume (MVV) of frequency volume chart (FVC) and maximum cystometric capacity (MCC) of filling cystometry in each posture and filling cystometry time. (A) First supine, (B) first erect, (C) second supine, and (D) second erect.</title></caption><graphic xlink:href="icu-58-34-g001"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Baseline demographics</title></caption><alternatives><graphic xlink:href="icu-58-34-i001"/><table frame="hsides" rules="rows"><col width="26.85%" span="1"/><col width="15.37%" span="1"/><col width="15.37%" span="1"/><col width="15.37%" span="1"/><col width="15.37%" span="1"/><col width="11.67%" span="1"/><thead><tr><th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(217,220,235)">Parameter</th><th valign="middle" align="center" rowspan="1" colspan="4" style="background-color:rgb(217,220,235)">Group</th><th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(217,220,235)">p-value<sup>a</sup></th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">SS (n=16)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">EE (n=16)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">SE (n=19)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">ES (n=20)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (y)</td><td valign="top" align="center" rowspan="1" colspan="1">68.8&#x000b1;6.1</td><td valign="top" align="center" rowspan="1" colspan="1">68.3&#x000b1;6.2</td><td valign="top" align="center" rowspan="1" colspan="1">68.6&#x000b1;6.6</td><td valign="top" align="center" rowspan="1" colspan="1">68.8&#x000b1;5.7</td><td valign="top" align="right" rowspan="1" colspan="1">0.706</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td valign="top" align="center" rowspan="1" colspan="1">24.9&#x000b1;2.0</td><td valign="top" align="center" rowspan="1" colspan="1">24.9&#x000b1;2.5</td><td valign="top" align="center" rowspan="1" colspan="1">24.3&#x000b1;2.4</td><td valign="top" align="center" rowspan="1" colspan="1">23.6&#x000b1;3.3</td><td valign="top" align="right" rowspan="1" colspan="1">0.401</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IPSS-T (0&#x02013;35)</td><td valign="top" align="center" rowspan="1" colspan="1">18.9&#x000b1;9.2</td><td valign="top" align="center" rowspan="1" colspan="1">16.3&#x000b1;8.3</td><td valign="top" align="center" rowspan="1" colspan="1">16.4&#x000b1;9.4</td><td valign="top" align="center" rowspan="1" colspan="1">16.9&#x000b1;9.0</td><td valign="top" align="right" rowspan="1" colspan="1">0.840</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IPSS-V (0&#x02013;20)</td><td valign="top" align="center" rowspan="1" colspan="1">11&#x000b1;6.0</td><td valign="top" align="center" rowspan="1" colspan="1">9.5&#x000b1;5.8</td><td valign="top" align="center" rowspan="1" colspan="1">9.5&#x000b1;6.6</td><td valign="top" align="center" rowspan="1" colspan="1">10.0&#x000b1;6.1</td><td valign="top" align="right" rowspan="1" colspan="1">0.892</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IPSS-S (0&#x02013;15)</td><td valign="top" align="center" rowspan="1" colspan="1">7.9&#x000b1;4.3</td><td valign="top" align="center" rowspan="1" colspan="1">6.7&#x000b1;4.6</td><td valign="top" align="center" rowspan="1" colspan="1">6.9&#x000b1;4.0</td><td valign="top" align="center" rowspan="1" colspan="1">6.9&#x000b1;3.9</td><td valign="top" align="right" rowspan="1" colspan="1">0.866</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OABSS score (0&#x02013;17)</td><td valign="top" align="center" rowspan="1" colspan="1">5.4&#x000b1;3.9</td><td valign="top" align="center" rowspan="1" colspan="1">4.9&#x000b1;3.6</td><td valign="top" align="center" rowspan="1" colspan="1">4.6&#x000b1;3.1</td><td valign="top" align="center" rowspan="1" colspan="1">4.8&#x000b1;3.4</td><td valign="top" align="right" rowspan="1" colspan="1">0.899</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OAB diagnosis</td><td valign="top" align="center" rowspan="1" colspan="1">11 (68.8)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (37.5)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (42.1)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (30.0)</td><td valign="top" align="right" rowspan="1" colspan="1">0.120</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PSA (ng/dL)</td><td valign="top" align="center" rowspan="1" colspan="1">2.8&#x000b1;2.2</td><td valign="top" align="center" rowspan="1" colspan="1">2.5&#x000b1;2.5</td><td valign="top" align="center" rowspan="1" colspan="1">2.7&#x000b1;2.1</td><td valign="top" align="center" rowspan="1" colspan="1">2.1&#x000b1;2.0</td><td valign="top" align="right" rowspan="1" colspan="1">0.753</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prostate volume (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">50.2&#x000b1;23.8</td><td valign="top" align="center" rowspan="1" colspan="1">51.3&#x000b1;20.9</td><td valign="top" align="center" rowspan="1" colspan="1">52.5&#x000b1;19.7</td><td valign="top" align="center" rowspan="1" colspan="1">52.1&#x000b1;19.5</td><td valign="top" align="right" rowspan="1" colspan="1">0.989</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FVC parameters</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="right" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;MVV (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">333.4&#x000b1;87.9</td><td valign="top" align="center" rowspan="1" colspan="1">341.3&#x000b1;94.3</td><td valign="top" align="center" rowspan="1" colspan="1">365.0&#x000b1;102.9</td><td valign="top" align="center" rowspan="1" colspan="1">381.1&#x000b1;93.7</td><td valign="top" align="right" rowspan="1" colspan="1">0.441</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;24-Hour frequency</td><td valign="top" align="center" rowspan="1" colspan="1">10.1&#x000b1;4.6</td><td valign="top" align="center" rowspan="1" colspan="1">9.0&#x000b1;4.1</td><td valign="top" align="center" rowspan="1" colspan="1">10.2&#x000b1;4.0</td><td valign="top" align="center" rowspan="1" colspan="1">9.3&#x000b1;3.2</td><td valign="top" align="right" rowspan="1" colspan="1">0.783</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Nocturia</td><td valign="top" align="center" rowspan="1" colspan="1">2.3&#x000b1;0.9</td><td valign="top" align="center" rowspan="1" colspan="1">1.7&#x000b1;1.1</td><td valign="top" align="center" rowspan="1" colspan="1">2.4&#x000b1;1.1</td><td valign="top" align="center" rowspan="1" colspan="1">2.4&#x000b1;1.3</td><td valign="top" align="right" rowspan="1" colspan="1">0.202</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;24-Hour production (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">1,778.1&#x000b1;478.9</td><td valign="top" align="center" rowspan="1" colspan="1">1,707.3&#x000b1;437.3</td><td valign="top" align="center" rowspan="1" colspan="1">2,008.3&#x000b1;935.3</td><td valign="top" align="center" rowspan="1" colspan="1">2,001.6&#x000b1;677.5</td><td valign="top" align="right" rowspan="1" colspan="1">0.463</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>Values are presented as mean&#x000b1;standard deviation or number (%).</p><p>SS, supine to supine; EE, erect to erect; SE, supine to erect; ES, erect to supine; BMI, body mass index; IPSS, International Prostate Symptom Score; IPSS-T, total IPSS score; IPSS-V, IPSS voiding subscore; IPSS-S, IPSS storage subscore; OABSS, overactive bladder symptom score; OAB, overactive bladder; PSA, prostate-specific antigen; FVC, frequency volume chart; MVV, maximum voided volume.</p><p><sup>a</sup>:One-way analysis of variance.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Change of filling cystometric parameters by repetition of filling cystometry in the same group</title></caption><alternatives><graphic xlink:href="icu-58-34-i002"/><table frame="hsides" rules="rows"><col width="18.54%" span="1"/><col width="7.7%" span="1"/><col width="7.7%" span="1"/><col width="5.48%" span="1"/><col width="7.83%" span="1"/><col width="7.83%" span="1"/><col width="5.48%" span="1"/><col width="7.31%" span="1"/><col width="7.31%" span="1"/><col width="5.48%" span="1"/><col width="6.92%" span="1"/><col width="6.92%" span="1"/><col width="5.48%" span="1"/><thead><tr><th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(217,220,235)">Parameter</th><th valign="middle" align="center" rowspan="1" colspan="3" style="background-color:rgb(217,220,235)">Group SS (n=16)</th><th valign="middle" align="center" rowspan="1" colspan="3" style="background-color:rgb(217,220,235)">Group EE (n=16)</th><th valign="middle" align="center" rowspan="1" colspan="3" style="background-color:rgb(217,220,235)">Group SE (n=19)</th><th valign="middle" align="center" rowspan="1" colspan="3" style="background-color:rgb(217,220,235)">Group ES (n=20)</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">1st CMG (supine)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">2nd CMG (supine)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">p-value</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">1st CMG (erect)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">2nd CMG (erect)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">p-value</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">1st CMG (supine)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">2nd CMG (erect)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">p-value</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">1st CMG (erect)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">2nd CMG (supine)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">p-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">FSF (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">238.7&#x000b1;82.8</td><td valign="top" align="center" rowspan="1" colspan="1">276.8&#x000b1;96.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.017</td><td valign="top" align="center" rowspan="1" colspan="1">147.4&#x000b1;79.4</td><td valign="top" align="center" rowspan="1" colspan="1">198.8&#x000b1;116.5</td><td valign="top" align="center" rowspan="1" colspan="1">0.072</td><td valign="top" align="center" rowspan="1" colspan="1">212.3&#x000b1;77.1</td><td valign="top" align="center" rowspan="1" colspan="1">189.6&#x000b1;87.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.273</td><td valign="top" align="center" rowspan="1" colspan="1">130.8&#x000b1;92.0</td><td valign="top" align="center" rowspan="1" colspan="1">215.5&#x000b1;91.9</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FDV (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">238.9&#x000b1;21.4</td><td valign="top" align="center" rowspan="1" colspan="1">277.0&#x000b1;96.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.017</td><td valign="top" align="center" rowspan="1" colspan="1">152.1&#x000b1;84.7</td><td valign="top" align="center" rowspan="1" colspan="1">203.6&#x000b1;116.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.068</td><td valign="top" align="center" rowspan="1" colspan="1">214.7&#x000b1;77.8</td><td valign="top" align="center" rowspan="1" colspan="1">190.0&#x000b1;87.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.223</td><td valign="top" align="center" rowspan="1" colspan="1">144.6&#x000b1;98.9</td><td valign="top" align="center" rowspan="1" colspan="1">216.4&#x000b1;94.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SDV (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">369.7&#x000b1;94.1</td><td valign="top" align="center" rowspan="1" colspan="1">392.6&#x000b1;103.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.061</td><td valign="top" align="center" rowspan="1" colspan="1">262.5&#x000b1;121.7</td><td valign="top" align="center" rowspan="1" colspan="1">266.4&#x000b1;130.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.808</td><td valign="top" align="center" rowspan="1" colspan="1">352.4&#x000b1;117.3</td><td valign="top" align="center" rowspan="1" colspan="1">298.2&#x000b1;120.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.018</td><td valign="top" align="center" rowspan="1" colspan="1">311.5&#x000b1;133.0</td><td valign="top" align="center" rowspan="1" colspan="1">395.2&#x000b1;106.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MCC (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">355.6&#x000b1;107.3</td><td valign="top" align="center" rowspan="1" colspan="1">376.2&#x000b1;119.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.073</td><td valign="top" align="center" rowspan="1" colspan="1">305.4&#x000b1;152.7</td><td valign="top" align="center" rowspan="1" colspan="1">318.0&#x000b1;162.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.429</td><td valign="top" align="center" rowspan="1" colspan="1">373.7&#x000b1;123.8</td><td valign="top" align="center" rowspan="1" colspan="1">323.0&#x000b1;132.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.009</td><td valign="top" align="center" rowspan="1" colspan="1">268.7&#x000b1;153.6</td><td valign="top" align="center" rowspan="1" colspan="1">381.3&#x000b1;131.0</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bladder compliance (mL/cmH<sub>2</sub>O)</td><td valign="top" align="center" rowspan="1" colspan="1">72.5&#x000b1;44.8</td><td valign="top" align="center" rowspan="1" colspan="1">72.5&#x000b1;40.8</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td><td valign="top" align="center" rowspan="1" colspan="1">44.5&#x000b1;25.2</td><td valign="top" align="center" rowspan="1" colspan="1">46.3&#x000b1;23.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.437</td><td valign="top" align="center" rowspan="1" colspan="1">62.1&#x000b1;40.2</td><td valign="top" align="center" rowspan="1" colspan="1">55.4&#x000b1;31.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.152</td><td valign="top" align="center" rowspan="1" colspan="1">44.6&#x000b1;39.3</td><td valign="top" align="center" rowspan="1" colspan="1">62.6&#x000b1;37.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Occurrence of DO</td><td valign="top" align="center" rowspan="1" colspan="1">6 (37.5)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (25.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.500<sup>a</sup></td><td valign="top" align="center" rowspan="1" colspan="1">14 (87.5)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (81.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1.000<sup>a</sup></td><td valign="top" align="center" rowspan="1" colspan="1">7 (36.8)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (68.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.031<sup>a</sup></td><td valign="top" align="center" rowspan="1" colspan="1">18 (90.0)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (35.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.001<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Minimum volume of DO (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">329.0&#x000b1;129.5</td><td valign="top" align="center" rowspan="1" colspan="1">363.3&#x000b1;177.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.408</td><td valign="top" align="center" rowspan="1" colspan="1">153.7&#x000b1;95.4</td><td valign="top" align="center" rowspan="1" colspan="1">221.1&#x000b1;126.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.007</td><td valign="top" align="center" rowspan="1" colspan="1">334.9&#x000b1;137.8</td><td valign="top" align="center" rowspan="1" colspan="1">201.9&#x000b1;19.5</td><td valign="top" align="center" rowspan="1" colspan="1">0.008</td><td valign="top" align="center" rowspan="1" colspan="1">99.6&#x000b1;99.7</td><td valign="top" align="center" rowspan="1" colspan="1">257.1&#x000b1;165.5</td><td valign="top" align="center" rowspan="1" colspan="1">0.014</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Maximum pressure of DO (cmH<sub>2</sub>O)</td><td valign="top" align="center" rowspan="1" colspan="1">25.6&#x000b1;26.4</td><td valign="top" align="center" rowspan="1" colspan="1">19.8&#x000b1;22.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.204</td><td valign="top" align="center" rowspan="1" colspan="1">44.7&#x000b1;25.2</td><td valign="top" align="center" rowspan="1" colspan="1">35.3&#x000b1;19.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.053</td><td valign="top" align="center" rowspan="1" colspan="1">20.4&#x000b1;19.5</td><td valign="top" align="center" rowspan="1" colspan="1">44.4&#x000b1;23.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.003</td><td valign="top" align="center" rowspan="1" colspan="1">74.3&#x000b1;19.0</td><td valign="top" align="center" rowspan="1" colspan="1">48.1&#x000b1;25.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.006</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>Values are presented as mean&#x000b1;standard deviation or number (%).</p><p>SS, supine to supine; EE, erect to erect; SE, supine to erect; ES, erect to supine; CMG, cystometrogram; FSF, first sensation of filling; FDV, first desire to void; SDV, strong desire to void; MCC, maximum cystometric capacity; DO, detrusor overactivity.</p><p><sup>a</sup>:McNemar test.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Comparison of clinical and urodynamic parameters in each posture of the first filling cystometry</title></caption><alternatives><graphic xlink:href="icu-58-34-i003"/><table frame="hsides" rules="rows"><col width="44%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="16%" span="1"/><thead><tr><th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(217,220,235)">Parameter</th><th valign="middle" align="center" rowspan="1" colspan="2" style="background-color:rgb(217,220,235)">1st posture</th><th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(217,220,235)">p-value</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">Supine (n=35)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">Erect (n=36)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">OAB diagnosis</td><td valign="top" align="center" rowspan="1" colspan="1">19 (54.3)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (33.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.096<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FVC</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;MVV (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">350.2&#x000b1;96.0</td><td valign="top" align="center" rowspan="1" colspan="1">363.5&#x000b1;94.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.565</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Uroflowmetry</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Qmax (mL/s)</td><td valign="top" align="center" rowspan="1" colspan="1">11.7&#x000b1;4.7</td><td valign="top" align="center" rowspan="1" colspan="1">13.0&#x000b1;5.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.408</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;PVR (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">49.9&#x000b1;36.9</td><td valign="top" align="center" rowspan="1" colspan="1">57.8&#x000b1;55.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.610</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Filling cystometry</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;FSF (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">223.9&#x000b1;79.5</td><td valign="top" align="center" rowspan="1" colspan="1">138.2&#x000b1;85.8</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;FDV (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">225.4&#x000b1;79.9</td><td valign="top" align="center" rowspan="1" colspan="1">148.0&#x000b1;91.4</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;SDV (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">360.8&#x000b1;105.3</td><td valign="top" align="center" rowspan="1" colspan="1">283.0&#x000b1;126.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.013</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;MCC (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">365.5&#x000b1;115.2</td><td valign="top" align="center" rowspan="1" colspan="1">285.0&#x000b1;152.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.015</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Bladder compliance (mL/cmH<sub>2</sub>O)</td><td valign="top" align="center" rowspan="1" colspan="1">66.9&#x000b1;42.1</td><td valign="top" align="center" rowspan="1" colspan="1">44.6&#x000b1;32.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.017</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Occurrence of DO</td><td valign="top" align="center" rowspan="1" colspan="1">13 (37.1)</td><td valign="top" align="center" rowspan="1" colspan="1">32 (88.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup>a</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Minimum volume of DO (mL)</td><td valign="top" align="center" rowspan="1" colspan="1">307.5&#x000b1;135.2</td><td valign="top" align="center" rowspan="1" colspan="1">134.8&#x000b1;96.5</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Maximum pressure of DO (cmH<sub>2</sub>O)</td><td valign="top" align="center" rowspan="1" colspan="1">22.6&#x000b1;20.6</td><td valign="top" align="center" rowspan="1" colspan="1">45.5&#x000b1;29.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.012</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pressure flow study</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;BOOI</td><td valign="top" align="center" rowspan="1" colspan="1">31.9&#x000b1;15.5</td><td valign="top" align="center" rowspan="1" colspan="1">27.9&#x000b1;20.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.380</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Urethral pressure measurement</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;MUCP (cmH<sub>2</sub>O)</td><td valign="top" align="center" rowspan="1" colspan="1">87.1&#x000b1;24.2</td><td valign="top" align="center" rowspan="1" colspan="1">75.7&#x000b1;21.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.038</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>Values are presented as number (%) or mean&#x000b1;standard deviation.</p><p>OAB, overactive bladder; FVC, frequency volume chart; MVV, maximum voided volume; Qmax, maximal flow rate; PVR, post-voided residual; FSF, first sensation of filling; FDV, first desire to void; SDV, strong desire to void; MCC, maximum cystometric capacity; DO, detrusor overactivity; BOOI, bladder outlet obstruction index; MUCP, maximum urethral closure pressure.</p><p><sup>a</sup>:Chi-square test.</p></fn></table-wrap-foot></table-wrap></floats-group></article>